24/7 Market News Snapshot 02 September, 2025 – Strata Skin Sciences, Inc. Common Stock (NASDAQ:SSKN)

September 2, 2025

DENVER, Colo., 02 September, 2025 (www.247marketnews.com) – (NASDAQ:SSKN) are discussed in this article.
Strata Skin Sciences, Inc. (NASDAQ:SSKN), a prominent player in medical technology focused on dermatological treatments, is gaining attention in financial markets, with pre-market trading reflecting a remarkable increase of 62.23%. Strata’s stock jumped to $3.861, up sharply from the previous close of $2.380, supported by a trading volume of 11.46 million shares. This surge indicates strong investor interest and highlights the company’s positive market sentiment as it approaches critical resistance levels.

Simultaneously, Strata has announced significant advancements in its intellectual property strategy aimed at enhancing patient care through its proprietary technologies. The company has established strong patent protections for its XTRAC excimer laser, enhancing its market exclusivity in combination with JAK inhibitors and other systemic treatments.

Strata plans to introduce expanded Current Procedural Terminology (CPT) codes in alignment with the Centers for Medicare & Medicaid Services (CMS) physician fee schedule by January 1, 2026. This initiative is expected to broaden reimbursement eligibility for a range of inflammatory and autoimmune skin conditions, including psoriasis, vitiligo, and alopecia areata, effectively tripling the patient market for its innovative therapies.

Dr. Dolev Rafaeli, President and CEO, expressed confidence in the company’s long-term growth strategy, emphasizing that the investment in intellectual property is crucial for expanding treatment options for patients facing complex dermatological issues. Strata’s innovative combination therapies, protected by three essential patents, are poised to revolutionize dermatology by integrating localized phototherapy with systemic treatments, aiming to enhance patient outcomes.

As the healthcare landscape pivots toward personalized medicine, Strata Skin Sciences is steadfast in its mission to deliver cutting-edge solutions, reinforcing its dedication to improving patient care while creating substantial value for stakeholders. The evolving dynamics of Strata’s advancements position the company favorably in the competitive healthcare market.

Related news for (SSKN)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.